Literature DB >> 11904136

Transcranial magnetic stimulation (TMS) effects on testosterone, prolactin, and corticosterone in adult male rats.

Dawson W Hedges1, David L Salyer, Brian J Higginbotham, Trent D Lund, James L Hellewell, David Ferguson, Edwin D Lephart.   

Abstract

BACKGROUND: Transcranial magnetic stimulation is a relatively new technique for inducing small, localized, and reversible changes in living brain tissue. Although transcranial magnetic stimulation generally results in no immediate changes in plasma corticosterone, prolactin, and testosterone, it normalizes the dexamethasone suppression test in some depressed subjects and has been shown to attenuate stress-induced increases in adrenocorticotropic hormone in rats.
METHODS: In this study, serum corticosterone and testosterone concentrations were assayed in male rats immediately and 3, 6, 9, 12, 24, and 48 hours following a single transcranial magnetic stimulation or sham application. Serum prolactin concentrations were determined immediately and 2 hours following a one-time application of either transcranial magnetic stimulation or sham.
RESULTS: Transcranial magnetic stimulation animals displayed significantly lower corticosterone concentrations at 6 and 24 hours following a single application compared with sham-control values. Transcranial magnetic stimulation also resulted in lower corticosterone concentrations numerically but not statistically in transcranial magnetic stimulation animals immediately after application (p =.089). No significant differences were found between groups for serum prolactin or testosterone levels at any given collection time point.
CONCLUSIONS: These findings 1) suggest that transcranial magnetic stimulation alters the hypothalamic-pituitary-adrenal stress axis and 2) provide time-course data for the implications of the hormonal mechanism that may be involved in the actions of transcranial magnetic stimulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904136     DOI: 10.1016/s0006-3223(01)01266-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

Review 2.  Translational neuromodulation: approximating human transcranial magnetic stimulation protocols in rats.

Authors:  Andrew M Vahabzadeh-Hagh; Paul A Muller; Roman Gersner; Abraham Zangen; Alexander Rotenberg
Journal:  Neuromodulation       Date:  2012-07-10

3.  Impact of one HF-rTMS session over the DLPFC and motor cortex on acute hormone dynamics and emotional state in healthy adults: a sham-controlled pilot study.

Authors:  Blair T Crewther; Wiktoria Kasprzycka; Christian J Cook; Rafał Rola
Journal:  Neurol Sci       Date:  2021-05-26       Impact factor: 3.830

4.  Effects of weekly low-frequency rTMS on autonomic measures in children with autism spectrum disorder.

Authors:  Manuel Fernando Casanova; Marie K Hensley; Estate M Sokhadze; Ayman S El-Baz; Yao Wang; Xiaoli Li; Lonnie Sears
Journal:  Front Hum Neurosci       Date:  2014-10-21       Impact factor: 3.169

5.  Combined repetitive transcranial magnetic stimulation and medication treatment for depression is associated with serum amyloid a level: Evidence from naturalistic clinical practice.

Authors:  You Xu; Li Han; Youdan Wei; Hongjing Mao; Zhenghe Yu
Journal:  Front Neurosci       Date:  2022-09-14       Impact factor: 5.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.